These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 27624916)

  • 1. Improving survival and local control in rectal cancer in Catalonia (Spain) in the context of centralisation: A full cycle audit assessment.
    Manchon-Walsh P; Aliste L; Espinàs JA; Prades J; Guarga A; Balart J; Biondo S; Castells A; Sanjuan X; Tabernero J; Borras JM;
    Eur J Surg Oncol; 2016 Dec; 42(12):1873-1880. PubMed ID: 27624916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variability in the quality of rectal cancer care in public hospitals in Catalonia (Spain): clinical audit as a basis for action.
    Manchon-Walsh P; Borras JM; Espinas JA; Aliste L;
    Eur J Surg Oncol; 2011 Apr; 37(4):325-33. PubMed ID: 21296543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in management and outcome of patients with rectal cancer in Northern Ireland: 1996-2006.
    McClements J; Fitzpatrick D; Campbell WJ; Gavin A
    Colorectal Dis; 2014 Feb; 16(2):O58-65. PubMed ID: 24447714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of hospital volume on long-term oncological outcome after rectal cancer surgery.
    Jonker FHW; Hagemans JAW; Burger JWA; Verhoef C; Borstlap WAA; Tanis PJ;
    Int J Colorectal Dis; 2017 Dec; 32(12):1741-1747. PubMed ID: 28884251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved quality of care for patients undergoing an abdominoperineal excision for rectal cancer.
    Bökkerink GM; Buijs EF; de Ruijter W; Rosman C; Sietses C; Strobel R; Heisterkamp J; Nagtegaal ID; Bremers AJ; de Wilt JH
    Eur J Surg Oncol; 2015 Feb; 41(2):201-7. PubMed ID: 25572974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer Center Volume and Type Impact Stage-Specific Utilization of Neoadjuvant Therapy in Rectal Cancer.
    Midura EF; Jung AD; Daly MC; Hanseman DJ; Davis BR; Shah SA; Paquette IM
    Dig Dis Sci; 2017 Aug; 62(8):1906-1912. PubMed ID: 28501970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving clinical outcomes through centralization of rectal cancer surgery and clinical audit: a mixed-methods assessment.
    Prades J; Manchon-Walsh P; Solà J; Espinàs JA; Guarga A; Borras JM
    Eur J Public Health; 2016 Aug; 26(4):538-42. PubMed ID: 26739995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the choice of hospital increase a chance of survival in rectal cancer?
    Pawlak M; Morawiec Z; Dziki Ł; Morawiec J; Kolacińska A; Dziki A
    Pol Przegl Chir; 2012 Dec; 84(12):638-45. PubMed ID: 23399631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Downstaging after neoadjuvant therapy for rectal cancer modifies the planned original surgery].
    Scutari F; Tramutola G; Morlino A; Rossi MT; Manzione L; Rosati G; Sopranzi A
    G Chir; 2008; 29(6-7):277-80. PubMed ID: 18544264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of rectal cancer surgery and its relationship to surgeon and hospital caseload: a population-based study.
    Comber H; Sharp L; Timmons A; Keane FB
    Colorectal Dis; 2012 Oct; 14(10):e692-700. PubMed ID: 22731759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrence rates and prognostic factors in ypN0 rectal cancer after neoadjuvant chemoradiation and total mesorectal excision.
    Govindarajan A; Reidy D; Weiser MR; Paty PB; Temple LK; Guillem JG; Saltz LB; Wong WD; Nash GM
    Ann Surg Oncol; 2011 Dec; 18(13):3666-72. PubMed ID: 21590450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Influence of Hospital Volume on Circumferential Resection Margin Involvement: Results of the Dutch Surgical Colorectal Audit.
    Gietelink L; Henneman D; van Leersum NJ; de Noo M; Manusama E; Tanis PJ; Tollenaar RA; Wouters MW;
    Ann Surg; 2016 Apr; 263(4):745-50. PubMed ID: 25790120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter study of outcome in relation to the type of resection in rectal cancer.
    Ortiz H; Wibe A; Ciga MA; Kreisler E; Garcia-Granero E; Roig JV; Biondo S;
    Dis Colon Rectum; 2014 Jul; 57(7):811-22. PubMed ID: 24901681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality assurance in rectal cancer treatment.
    van de Velde CJ; van den Broek CB
    Dig Dis; 2012; 30 Suppl 2():126-31. PubMed ID: 23207944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of hospital volume on quality indicators for rectal cancer surgery in British Columbia, Canada.
    McColl RJ; McGahan CE; Cai E; Olson R; Cheung WY; Raval MJ; Phang PT; Karimuddin AA; Brown CJ
    Am J Surg; 2017 Feb; 213(2):388-394. PubMed ID: 27575600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time trends, improvements and national auditing of rectal cancer management over an 18-year period.
    Kodeda K; Johansson R; Zar N; Birgisson H; Dahlberg M; Skullman S; Lindmark G; Glimelius B; Påhlman L; Martling A
    Colorectal Dis; 2015 Sep; 17(9):O168-79. PubMed ID: 26155848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Centralisation of radical cystectomies for bladder cancer in England, a decade on from the 'Improving Outcomes Guidance': the case for super centralisation.
    Afshar M; Goodfellow H; Jackson-Spence F; Evison F; Parkin J; Bryan RT; Parsons H; James ND; Patel P
    BJU Int; 2018 Feb; 121(2):217-224. PubMed ID: 28594471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in nationwide use of preoperative radiotherapy for rectal cancer after revision of the national colorectal cancer guideline.
    Gietelink L; Wouters MWJM; Marijnen CAM; van Groningen J; van Leersum N; Beets-Tan RGH; Tollenaar RAEM; Tanis PJ;
    Eur J Surg Oncol; 2017 Jul; 43(7):1297-1303. PubMed ID: 28351504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of hospital procedure volume on surgical operation and long-term outcomes in high-risk curatively resected rectal cancer: findings from the Intergroup 0114 Study.
    Meyerhardt JA; Tepper JE; Niedzwiecki D; Hollis DR; Schrag D; Ayanian JZ; O'Connell MJ; Weeks JC; Mayer RJ; Willett CG; MacDonald JS; Benson AB; Fuchs CS
    J Clin Oncol; 2004 Jan; 22(1):166-74. PubMed ID: 14701779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Could a wait and see policy be justified in T3/4 rectal cancers after chemo-radiotherapy?
    Hughes R; Harrison M; Glynne-Jones R
    Acta Oncol; 2010 Apr; 49(3):378-81. PubMed ID: 20151936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.